Population Management of Diabetes in a High-Need Urban Community in the Bronx

SAGE: May 14, 2013 The Experience of Montefiore Medical Center Purpose The purpose of this study is to examine the impact of a Care Management Organization (CMO) Diabetes Disease Management Program (DDMP) in improving diabetes outcomes among high-risk patients with type 2 diabetes (T2DM) in the Bronx, New York. Methods An interventional, nonrandomized study design was used […]

Clinical Inertia in People With Type 2 Diabetes

ADA:  July 22, 2013 A retrospective cohort study of more than 80,000 people OBJECTIVE To determine time to treatment intensification in people with type 2 diabetes treated with one, two, or three oral antidiabetes drugs (OADs) and associated levels of glycemic control. RESEARCH DESIGN AND METHODS This was a retrospective cohort study based on 81,573 people with […]

Overtreatment common in high-risk diabetes patients

Family Practice News Digital Network: 07/22/13 CHICAGO – Glycemic overtreatment of high-risk diabetic patients is rampant within the Veterans Affairs health care system, according to a national study. Moreover, because many of these diabetic veterans who are at high risk for serious hypoglycemia are also Medicare eligible, it’s quite likely that overtreatment is a common problem […]

The Democratization of Health Care: Advancing the Analog to Digital Medicine Evolution

The Huffington Post:  07/11/2013 pm Imagine the upheaval in our economy — on manufacturers, on jobs, on wages, on the availability of consumable goods — if, with the stroke of a pen, the cost of cars, computers, homes, land, clothing or food were reduced by 72 percent. Effective July 1, 2013 the Centers for Medicare […]

AACE Comprehensive Diabetes Management Algorithm

AACE: 7/11/13 NEW! American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement published in Endocr Pract. 2013;19 (Suppl 1):1-48 Lifestyle optimization is essential for all pa-tients with diabetes. This is multifaceted, ongoing, and engages the entire diabetes team. However, such efforts should not delay needed pharmacotherapy, which can be initi-ated simultaneously and adjusted […]

Declines in Lower Extremity Amputation in the US Medicare Population, 2000-2010

SAGE: February 5, 2013 Background: Despite evidence that improved outcomes are associated with more distal lower extremity amputations (LEA), the impact of recent advances in the orthopedic approach to diabetic foot ulcer (DFU) on the use and anatomic level of LEAs is unknown. Methods: We queried the complete Medicare Part B claims database (2000-2010) for volume and […]

Mortality by Race Among Low-Income Adults With Early-Onset Insulin-Treated Diabetes

Diabetes Care: July 8, 2013 OBJECTIVE To determine if long-term mortality rates in early-onset insulin-treated diabetes differ by race among adults of similar socioeconomic status. RESEARCH DESIGN AND METHODS A total of 391 (299 African Americans, 92 whites) mostly low-income adults 40–79 years of age with insulin-treated diabetes diagnosed before 30 years of age were recruited from community […]

New Research, Videos, and Infographics Tackle Latino Childhood Obesity Issues

Salud-America: 7/1/13 This summer, Salud America! is releasing six packages of research materials—each with a research review, issue brief, video and infographic—on different aspects of Latino childhood obesity issues and potential solutions. Read more

Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study

Springer: 6/5/13 Pediatric metabolic syndrome (MS) and its cardiometabolic components (MSCs) have become increasingly prevalent, yet little is known about the genetics underlying MS risk in children. We examined the prevalence and genetics of MS-related traits among 670 non-diabetic Mexican American (MA) children and adolescents, aged 6–17 years (49 % female), who were participants in the San Antonio […]

Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

ADA: July 8, 2013 Atypical antipsychotic (AAP) medications that have revolutionized the treatment of mental illness have become stigmatized by metabolic side effects, including obesity and diabetes. It remains controversial whether the defects are treatment induced or disease related. Although the mechanisms underlying these metabolic defects are not understood, it is assumed that the initiating […]

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2012 National Minority Quality Forum, Inc. All Rights Reserved.